Appointment
Innate Pharma: Change at the top
Mahjoubi will take over as Chairman of Innate Pharma’s Executive Board at the end of December. Brailly, in turn, is set to become Chairman of the Supervisory Board.
Mahjoubi is a medical oncologist trained at Institut Gustave Roussy in Paris. At AstraZeneca, he was instrumental in driving the oncology. Before AstraZeneca, he worked for pharma companies such as Aventis, Sanofi and Roche-Genentech.